High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience ; volume:58 ; number:11 ; day:23 ; month:8 ; year:2023 ; pages:1229-1236 ; date:11.2023
Bone marrow transplantation ; 58, Heft 11 (23.8.2023), 1229-1236, 11.2023
- Creator
-
Kabut, Tomáš
Weinbergerová, Barbora
Folber, František
Lengerová, Martina
Mayer, Jiří
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41409-023-02081-6
- URN
-
urn:nbn:de:101:1-2024012210520026732784
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kabut, Tomáš
- Weinbergerová, Barbora
- Folber, František
- Lengerová, Martina
- Mayer, Jiří
- SpringerLink (Online service)
Other Objects (12)
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data
Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular Immunity
High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation
Cytomegalievirus (CMV)-Primärinfektion und kongenitale CMV (cCMV)-Infektion in Sachsen-Anhalt
Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients
Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms
Ambulatory high-dose methotrexate administration as central nervous system prophylaxis in patients with aggressive lymphoma
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data
Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular Immunity
High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation
Cytomegalievirus (CMV)-Primärinfektion und kongenitale CMV (cCMV)-Infektion in Sachsen-Anhalt
Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients
Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms
Ambulatory high-dose methotrexate administration as central nervous system prophylaxis in patients with aggressive lymphoma
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data
Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular Immunity
High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation
Cytomegalievirus (CMV)-Primärinfektion und kongenitale CMV (cCMV)-Infektion in Sachsen-Anhalt
Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients
Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms